• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
AYTU

AYTU

Aytu BioPharma, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD2.09

-0.01 (-0.48%)

Rating:C-

Company Profile

CEO

Joshua R. Disbrow

IPO Date

2008-09-25

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.11

Prev. Close

$2.10

Day Low

$2.08

Day High

$2.14

52W Low

$1.46

52W High

$3.07

Market Cap

$0.02B

Volume

0.03M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

36.3%

Avg Negative

22.4%

Avg Neutral

41.6%

News Feed

Aytu BioPharma Announces Publication of Data Demonstrating Ultraviolet-A Light Reduces Cellular Cytokine Release from Human Endotracheal Cells Infected with Coronavirus

Accesswire·7/27/2021·↑ positive

Implied Volatility Surging for Aytu Biopharma (AYTU) Stock Options

Zacks Investment Research·7/7/2021·↓ negative

Aytu BioPharma Announces Peer-Reviewed Publication of Clinical Results from Healight(TM) Pilot Study

Accesswire·6/28/2021·↑ positive

Technical Levels To Watch In Aytu BioPharma Stock

Benzinga·6/21/2021·↑ positive

What's Next For Aytu BioPharma Stock As It Gaps Up To Resistance?

Benzinga·6/8/2021·↓ negative

Aytu BioPharma to Present at Upcoming June Investor Conferences

Accesswire·5/25/2021·↑ positive

Aytu Biopharma, Inc. (AYTU) CEO Joshua Disbrow on Q3 2021 Results - Earnings Call Transcript

Seeking Alpha·5/17/2021·↓ negative

Recap: Aytu BioPharma Q3 Earnings

Benzinga·5/17/2021·↓ negative

Aytu BioPharma Reports Fiscal Third Quarter 2021 Financial Results and Recent Business Highlights

Accesswire·5/17/2021·↑ positive

Aytu BioPharma Announces Publication of In Vitro Study Demonstrating That Ultraviolet-A Light Increases Mitochondrial Anti-Viral Signaling Protein Within Cells

Accesswire·5/12/2021·↑ positive